FY26
Assets2,792.10
Net Worth1,912.30
Total Debt221.70
RevenueAnnualised basis1,848.70
EBITDAAnnualised basis663.30
PATAnnualised basis436.70
EBITDA Margin (%)35.88
At a glance
Updated 2026-08-29Encube Ethicals is an IPO, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets1,871.80₹ Cr · -18.6% vs prior year
Net Worth1,241.20₹ Cr · -16.9% vs prior year
FY25
Assets2,300.10
Net Worth1,492.90
Total Debt230.50
RevenueAnnualised basis1,344.80
EBITDAAnnualised basis452.10
PATAnnualised basis249.60
EBITDA Margin (%)33.62
FY24
Assets1,871.80
Net Worth1,241.20
Total Debt228.10
RevenueAnnualised basis1,085.90
EBITDAAnnualised basis297.60
PATAnnualised basis156.10
EBITDA Margin (%)27.41
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Encube Ethicals IPO | — | - | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
| Sudeep Pharma IPO | — | 53.55 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-29.
IPO UPDATE ALERTS
Register for IPO Updates →Track Encube Ethicals without missing an update
Register for subscription, GMP, allotment and listing notifications.